IDEAS home Printed from https://ideas.repec.org/r/plo/pmed00/0050045.html
   My bibliography  Save this item

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Garret Christensen & Edward Miguel, 2018. "Transparency, Reproducibility, and the Credibility of Economics Research," Journal of Economic Literature, American Economic Association, vol. 56(3), pages 920-980, September.
  2. Ad. J. W. van de Gevel & Charles N. Noussair, 2013. "The Nexus between Artificial Intelligence and Economics," SpringerBriefs in Economics, Springer, edition 127, number 978-3-642-33648-5, February.
  3. Busfield, Joan, 2015. "Assessing the overuse of medicines," Social Science & Medicine, Elsevier, vol. 131(C), pages 199-206.
  4. Cronin, C.J.; Forsstrom, M.P.; Papageorge, N.W.;, 2017. "Mental Health, Human Capital and Labor Market Outcomes," Health, Econometrics and Data Group (HEDG) Working Papers 17/25, HEDG, c/o Department of Economics, University of York.
  5. Danielle Hen-Shoval & Aron Weller & Abraham Weizman & Gal Shoval, 2022. "Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review," IJERPH, MDPI, vol. 19(1), pages 1-19, January.
  6. Malcom Hopwood, 2020. "The Shared Decision-Making Process in the Pharmacological Management of Depression," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 13(1), pages 23-30, February.
  7. Janus Christian Jakobsen & Jane Lindschou Hansen & Erik Simonsen & Christian Gluud, 2011. "The Effect of Interpersonal Psychotherapy and other Psychodynamic Therapies versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder," PLOS ONE, Public Library of Science, vol. 6(4), pages 1-9, April.
  8. Nagel, Mats, 2020. "Changing perspectives: Towards detailed phenotyping in genetics," Thesis Commons a4nz2, Center for Open Science.
  9. Liebert, Rachel & Gavey, Nicola, 2009. ""There are always two sides to these things": Managing the dilemma of serious adverse effects from SSRIs," Social Science & Medicine, Elsevier, vol. 68(10), pages 1882-1891, May.
  10. Giuliano Masiero & Fabrizio Mazzonna & Sandro Steinbach & Olaf Verbeek, 2019. "The effect of local growth in antidepressant consumption on mental health outcomes," IdEP Economic Papers 1902, USI Università della Svizzera italiana.
  11. Giuliano Masiero & Fabrizio Mazzonna & Olaf Verbeek, 2018. "What drives the rise of antidepressant consumption? Evidence from Switzerland," IdEP Economic Papers 1801, USI Università della Svizzera italiana.
  12. Janet M. Currie & W. Bentley MacLeod, 2018. "Understanding Doctor Decision Making: The Case of Depression," NBER Working Papers 24955, National Bureau of Economic Research, Inc.
  13. Weisz, George & Knaapen, Loes, 2009. "Diagnosing and treating premenstrual syndrome in five western nations," Social Science & Medicine, Elsevier, vol. 68(8), pages 1498-1505, April.
  14. Bütikofer, Aline & Cronin, Christopher J. & Skira, Meghan M., 2020. "Employment effects of healthcare policy: Evidence from the 2007 FDA black box warning on antidepressants," Journal of Health Economics, Elsevier, vol. 73(C).
  15. Light, Donald W. & Lexchin, Joel R., 2021. "Pharmaceuticals as a market for “lemons”: Theory and practice," Social Science & Medicine, Elsevier, vol. 268(C).
  16. Bayer, Ya‘akov M. & Shtudiner, Zeev & Suhorukov, Oxsana & Grisaru, Nimrod, 2019. "Time and risk preferences, and consumption decisions of patients with clinical depression," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 78(C), pages 138-145.
  17. André Russowsky Brunoni & Mariana Lopes & Ted J Kaptchuk & Felipe Fregni, 2009. "Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 4(3), pages 1-10, March.
  18. Michael A Sugarman & Amy M Loree & Boris B Baltes & Emily R Grekin & Irving Kirsch, 2014. "The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales," PLOS ONE, Public Library of Science, vol. 9(8), pages 1-15, August.
  19. Juan Antonio Zarza-Rebollo & Esther Molina & Elena López-Isac & Ana M. Pérez-Gutiérrez & Blanca Gutiérrez & Jorge A. Cervilla & Margarita Rivera, 2022. "Interaction Effect between Physical Activity and the BDNF Val66Met Polymorphism on Depression in Women from the PISMA-ep Study," IJERPH, MDPI, vol. 19(4), pages 1-13, February.
  20. Lekeisha A. Sumner* & Waguih William IsHak & Jonathan Dang, MD & Brigitte Vanle & Naina Mahtani & Itai Danovitch, 2018. "Psychological Interventions in Inpatient Medical Settings: A Brief Review," International Journal of Healthcare and Medical Sciences, Academic Research Publishing Group, vol. 4(5), pages 73-83, 05-2018.
  21. Megan Spencer-Smith & Torkel Klingberg, 2015. "Benefits of a Working Memory Training Program for Inattention in Daily Life: A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-18, March.
  22. Lennon, Carter A. & Huedo-Medina, Tania B. & Gerwien, Daniel P. & Johnson, Blair T., 2012. "A role for depression in sexual risk reduction for women? A meta-analysis of HIV prevention trials with depression outcomes," Social Science & Medicine, Elsevier, vol. 75(4), pages 688-698.
  23. William Hollingworth & Christopher G. Fawsitt & Padraig Dixon & Larisa Duffy & Ricardo Araya & Tim J. Peters & Howard Thom & Nicky J. Welton & Nicola Wiles & Glyn Lewis, 2020. "Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT," PharmacoEconomics - Open, Springer, vol. 4(3), pages 427-438, September.
  24. Lijuan Guo & Zhaowei Kong & Yanjie Zhang, 2019. "Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials," IJERPH, MDPI, vol. 16(5), pages 1-11, March.
  25. Klaus Munkholm & Stephanie Winkelbeiner & Philipp Homan, 2020. "Individual response to antidepressants for depression in adults-a meta-analysis and simulation study," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-16, August.
  26. Gandré, Coralie & Rosenberg, Sebastian & Coldefy, Magali & Or, Zeynep, 2019. "Experimenting locally with a stepped-care approach for the treatment of mild to moderate mental disorders in France: Challenges and opportunities," Health Policy, Elsevier, vol. 123(11), pages 1021-1027.
  27. Constantin Volkmann & Alexander Volkmann & Christian A Müller, 2020. "On the treatment effect heterogeneity of antidepressants in major depression: A Bayesian meta-analysis and simulation study," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-22, November.
  28. Bishop, Felicity L. & Jacobson, Eric E. & Shaw, Jessica R. & Kaptchuk, Ted J., 2012. "Scientific tools, fake treatments, or triggers for psychological healing: How clinical trial participants conceptualise placebos," Social Science & Medicine, Elsevier, vol. 74(5), pages 767-774.
  29. Petkova Eva & Tarpey Thaddeus & Govindarajulu Usha, 2009. "Predicting Potential Placebo Effect in Drug Treated Subjects," The International Journal of Biostatistics, De Gruyter, vol. 5(1), pages 1-27, July.
  30. Felicity Thomas & Lorraine Hansford & Joseph Ford & Katrina Wyatt & Rosemarie McCabe & Richard Byng, 2018. "Moral narratives and mental health: rethinking understandings of distress and healthcare support in contexts of austerity and welfare reform," Palgrave Communications, Palgrave Macmillan, vol. 4(1), pages 1-8, December.
  31. Janus Christian Jakobsen & Jane Lindschou Hansen & Ole Jakob Storebø & Erik Simonsen & Christian Gluud, 2011. "The Effects of Cognitive Therapy Versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder," PLOS ONE, Public Library of Science, vol. 6(8), pages 1-11, August.
  32. Michael P Hengartner & Janus C Jakobsen & Anders Sørensen & Martin Plöderl, 2020. "Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trial," PLOS ONE, Public Library of Science, vol. 15(2), pages 1-11, February.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.